BUFFALO GROVE, Ill.–(BUSINESS WIRE)–Phathom Pharmaceuticals, Inc. (Nasdaq: PHAT), a late clinical-stage biopharmaceutical company focused on developing and commercializing novel treatments for gastrointestinal diseases, announced today the closing of its previously […]

LA JOLLA, Calif.–(BUSINESS WIRE)–Silvergate Capital Corporation (“Silvergate” or the “Company”) announced the launch of its initial public offering of 3,744,307 shares of Class A common stock. Silvergate is offering 770,000 […]

BUFFALO GROVE, Ill.–(BUSINESS WIRE)–Phathom Pharmaceuticals, Inc. (Nasdaq: PHAT), a late clinical-stage biopharmaceutical company focused on developing and commercializing novel treatments for gastrointestinal diseases, announced today that it has priced its […]

CHICAGO–(BUSINESS WIRE)–Cresco Labs Inc. (“Cresco Labs” or the “Company”) (CSE: CL) (OTCQX: CRLBF), one of the largest vertically integrated multistate cannabis operators in the United States, announced today that, in […]

SANTA CLARA, Calif.–(BUSINESS WIRE)–#IPO–SiTime Corporation, a market leader in MEMS timing, today announced that it has publicly filed a registration statement on Form S-1 with the U.S. Securities and Exchange […]

NEW YORK–(BUSINESS WIRE)–Union Acquisition Corp. II (NASDAQ: LATNU) (the “Company”) announced today that it closed its initial public offering of 20,000,000 units, including 2,500,000 units subject to the underwriters’ over-allotment […]

NEW YORK–(BUSINESS WIRE)–Union Acquisition Corp. II (NASD: LATNU) (the “Company”) announced today that it priced its initial public offering of 17,500,000 units at $10.00 per unit. The units will commence […]

BUFORD, Ga.–(BUSINESS WIRE)–OneWater Marine Inc. (NASDAQ: ONEW) (“OneWater”) announced today that it has launched an initial public offering of 3,157,895 shares of its Class A common stock at an anticipated […]

PRINCETON, N.J.–(BUSINESS WIRE)–Oyster Point Pharma, Inc., a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization of first-in-class pharmaceutical therapies to treat ocular surface diseases, today announced that it […]

WOBURN, Mass.–(BUSINESS WIRE)–Frequency Therapeutics, Inc. (Nasdaq: FREQ), a clinical-stage biotechnology company focused on harnessing the body’s innate biology to repair or reverse damage caused by a broad range of degenerative […]